Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Designing and executing prime editing experiments in mammalian cells

Nature Protocols volume 17, pages 2431–2468 (2022)Cite this article

Subjects

Abstract

Prime editing (PE) is a precision gene editing technology that enables the programmable installation of substitutions, insertions and deletions in cells and animals without requiring double-strand DNA breaks (DSBs). The mechanism of PE makes it less dependent on cellular replication and endogenous DNA repair than homology-directed repair-based approaches, and its ability to precisely install edits without creating DSBs minimizes indels and other undesired outcomes. The capabilities of PE have also expanded since its original publication. Enhanced PE systems, PE4 and PE5, manipulate DNA repair pathways to increase PE efficiency and reduce indels. Other advances that improve PE efficiency include engineered pegRNAs (epegRNAs), which include a structured RNA motif to stabilize and protect pegRNA 3′ ends, and the PEmax architecture, which improves editor expression and nuclear localization. New applications such as twin PE (twinPE) can precisely insert or delete hundreds of base pairs of DNA and can be used in tandem with recombinases to achieve gene-sized (>5 kb) insertions and inversions. Achieving optimal PE requires careful experimental design, and the large number of parameters that influence PE outcomes can be daunting. This protocol describes current best practices for conducting PE and twinPE experiments and describes the design and optimization of pegRNAs. We also offer guidelines for how to select the proper PE system (PE1 to PE5 and twinPE) for a given application. Finally, we provide detailed instructions on how to perform PE in mammalian cells. Compared with other procedures for editing human cells, PE offers greater precision and versatility, and can be completed within 2–4 weeks.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Mechanism of PE.
Fig. 2: Architecture of an epegRNA.
Fig. 3: Experimental design of epegRNAs.
Fig. 4: Experimental design for twinPE.
Fig. 5: Design of a PE3b/PE5b nicking sgRNA.
Fig. 6: Experimental workflow for PE optimization.
Fig. 7: Example results.

Similar content being viewed by others

Data availability

Sequencing data used to generate Fig. 7 are deposited at the NCBI Sequence Read Archive database under PRJNA817825.

Code availability

The code used for HTS processing and analysis is accessible at https://github.com/pinellolab/CRISPResso2.

References

  1. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824–844 (2020).

    Article  CAS  PubMed  Google Scholar 

  3. Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 384, 252–260 (2021).

    Article  CAS  PubMed  Google Scholar 

  4. Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493–502 (2021).

    Article  CAS  PubMed  Google Scholar 

  5. Giannoukos, G. et al. UDiTaSTM, a genome editing detection method for indels and genome rearrangements. BMC Genomics 19, 212 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Stadtmauer, E. A. et al. CRISPR-engineered T cells in patients with refractory cancer. Science. 367, eaba7365 (2020).

    Article  CAS  PubMed  Google Scholar 

  7. Webber, B. R. et al. Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors. Nat. Commun. 10, 5222 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Turchiano, G. et al. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell 28, 1136–1147.e5 (2021).

    Article  CAS  PubMed  Google Scholar 

  9. Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765–771 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Song, Y. et al. Large-fragment deletions induced by Cas9 cleavage while not in the BEs system. Mol. Ther. Nucleic Acids 21, 523–526 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Zuccaro, M. V. et al. Allele-specific chromosome removal after Cas9 cleavage in human embryos. Cell. 183, 1650–1664.e15 (2020).

    Article  CAS  PubMed  Google Scholar 

  12. Alanis-Lobato, G. et al. Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos. Proc. Natl. Acad. Sci. USA 118, e2004832117 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Leibowitz, M. L. et al. Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing. Nat. Genet. 53, 895–905 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Enache, O. M. et al. Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nat. Genet. 52, 662–668 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121–131 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chapman, J. R., Taylor, M. R. G. & Boulton, S. J. Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell 47, 497–510 (2012).

    Article  CAS  PubMed  Google Scholar 

  18. Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420–424 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Nishida, K. et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. 353, aaf8729 (2016).

    Article  PubMed  Google Scholar 

  20. Gaudelli, N. M. et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551, 464–471 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883–891 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Newby, G. A. et al. Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature 595, 295–302 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Koblan, L. W. et al. In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice. Nature 589, 608–614 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Newby, G. A. & Liu, D. R. In vivo somatic cell base editing and prime editing. Mol. Ther. 29, 3107–3124 (2021).

    Article  CAS  PubMed  Google Scholar 

  25. Koblan, L. W. et al. Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning. Nat. Biotechnol. 39, 1414–1425 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Kurt, I. C. et al. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nat. Biotechnol. 39, 41–46 (2021).

    Article  CAS  PubMed  Google Scholar 

  27. Chen, L. et al. Programmable C:G to G:C genome editing with CRISPR-Cas9-directed base excision repair proteins. Nat. Commun. 12, 1384 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Yuan, T. et al. Optimization of C-to-G base editors with sequence context preference predictable by machine learning methods. Nat. Commun. 12, 4902 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Zhao, D. et al. Glycosylase base editors enable C-to-A and C-to-G base changes. Nat. Biotechnol. 39, 35–40 (2021).

    Article  CAS  PubMed  Google Scholar 

  30. Chen, P. J. et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 184, 5635–5652.e29 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Nelson, J. W. et al. Engineered pegRNAs improve prime editing efficiency. Nat. Biotechnol. 40, 402–410 (2022).

    Article  CAS  PubMed  Google Scholar 

  32. Kim, D. Y., Moon, S. B., Ko, J.-H., Kim, Y.-S. & Kim, D. Unbiased investigation of specificities of prime editing systems in human cells. Nucleic Acids Res. 48, 10576–10589 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Schene, I. F. et al. Prime editing for functional repair in patient-derived disease models. Nat. Commun. 11, 5352 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Gao, P. et al. Prime editing in mice reveals the essentiality of a single base in driving tissue-specific gene expression. Genome Biol. 22, 83 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Jin, S. et al. Genome-wide specificity of prime editors in plants. Nat. Biotechnol. 39, 1292–1299 (2021).

    Article  CAS  PubMed  Google Scholar 

  36. Habib, O., Habib, G., Hwang, G.-H. & Bae, S. Comprehensive analysis of prime editing outcomes in human embryonic stem cells. Nucleic Acids Res. 50, 1187–1197 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Liu, P. et al. Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice. Nat. Commun. 12, 2121 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Liu, Y. et al. Enhancing prime editing by Csy4-mediated processing of pegRNA. Cell Res. 31, 1134–1136 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Zhang, G. et al. Enhancement of prime editing via xrRNA motif-joined pegRNA. Nat. Commun. 13, 1856 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Petri, K. et al. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells. Nat. Biotechnol. 40, 189–193 (2022).

    Article  CAS  PubMed  Google Scholar 

  41. Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479–1491 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Hussmann, J. A. et al. Mapping the genetic landscape of DNA double-strand break repair. Cell 184, 5653–5669.e25 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Spencer, J. M. & Zhang, X. Deep mutational scanning of S. pyogenes Cas9 reveals important functional domains. Sci. Rep. 7, 16836 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  44. Park, S.-J. et al. Targeted mutagenesis in mouse cells and embryos using an enhanced prime editor. Genome Biol. 22, 170 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Song, M. et al. Generation of a more efficient prime editor 2 by addition of the Rad51 DNA-binding domain. Nat. Commun. 12, 5617 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Anzalone, A. V. et al. Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing. Nat. Biotechnol. 40, 731–740 (2022).

    Article  CAS  PubMed  Google Scholar 

  47. Choi, J. et al. Precise genomic deletions using paired prime editing. Nat. Biotechnol. 40, 218–226 (2022).

    Article  CAS  PubMed  Google Scholar 

  48. Jiang, T., Zhang, X.-O., Weng, Z. & Xue, W. Deletion and replacement of long genomic sequences using prime editing. Nat. Biotechnol. 40, 227–234 (2022).

    Article  CAS  PubMed  Google Scholar 

  49. Lin, Q. et al. High-efficiency prime editing with optimized, paired pegRNAs in plants. Nat. Biotechnol. 39, 923–927 (2021).

    Article  CAS  PubMed  Google Scholar 

  50. Zhuang, Y. et al. Increasing the efficiency and precision of prime editing with guide RNA pairs. Nat. Chem. Biol. 18, 29–37 (2022).

    Article  CAS  PubMed  Google Scholar 

  51. Wang, J. Efficient targeted insertion of large DNA fragments without DNA donors. Nat. Methods 19, 25 (2022).

    Article  Google Scholar 

  52. Tao, R. et al. Bi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells. Nucleic Acids Res. 50, 6423–6434 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  53. Ioannidi, E. I. et al. Drag-and-drop genome insertion without DNA cleavage with CRISPR-directed integrases. Preprint at BioRxiv https://doi.org/10.1101/2021.11.01.466786 (2021).

  54. Lin, Q. et al. Prime genome editing in rice and wheat. Nat. Biotechnol. 38, 582–585 (2020).

    Article  CAS  PubMed  Google Scholar 

  55. Zheng, C. et al. A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liver. Mol. Ther. 30, 1343–1351 (2022).

    Article  CAS  PubMed  Google Scholar 

  56. Zhi, S. et al. Dual-AAV delivering split prime editor system for in vivo genome editing. Mol. Ther. 30, 283–294 (2022).

    Article  CAS  PubMed  Google Scholar 

  57. Liu, Y. et al. Efficient generation of mouse models with the prime editing system. Cell Discov. 6, 1–4 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  58. Lin, J. et al. Modeling a cataract disorder in mice with prime editing. Mol. Ther. Nucleic Acids 25, 494–501 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Böck, D. et al. In vivo prime editing of a metabolic liver disease in mice. Sci. Transl. Med. 14, (2021).

  60. Kim, Y. et al. Adenine base editing and prime editing of chemically derived hepatic progenitors rescue genetic liver disease. Cell Stem Cell. 28, 1614–1624.e5 (2021).

    Article  CAS  PubMed  Google Scholar 

  61. Choi, J. et al. A time-resolved multi-symbol molecular recorder via sequential genome editing. Nature https://doi.org/10.1038/s41586-022-04922-8 (2022).

  62. Erwood, S. et al. Saturation variant interpretation using CRISPR prime editing. Nat. Biotechnol. 40, 885–895 (2022).

    Article  CAS  PubMed  Google Scholar 

  63. Xu, R., Liu, X., Li, J., Qin, R. & Wei, P. Identification of herbicide resistance OsACC1 mutations via in planta prime-editing-library screening in rice. Nat. Plants 7, 888–892 (2021).

    Article  CAS  PubMed  Google Scholar 

  64. Qian, Y. et al. Efficient and precise generation of Tay–Sachs disease model in rabbit by prime editing system. Cell Discov. 7, 50 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Jang, H. et al. Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases. Nat. Biomed. Eng. 6, 181–194 (2022).

    Article  CAS  PubMed  Google Scholar 

  66. Kim, H. K. et al. Predicting the efficiency of prime editing guide RNAs in human cells. Nat. Biotechnol. 39, 198–206 (2021).

    Article  CAS  PubMed  Google Scholar 

  67. Gao, Z., Herrera-Carrillo, E. & Berkhout, B. Delineation of the exact transcription termination signal for type 3 polymerase III. Mol. Ther. Nucleic Acids 10, 36–44 (2018).

    Article  CAS  PubMed  Google Scholar 

  68. Hsu, J. Y. et al. PrimeDesign software for rapid and simplified design of prime editing guide RNAs. Nat. Commun. 12, 1034 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Hwang, G.-H. et al. PE-Designer and PE-Analyzer: web-based design and analysis tools for CRISPR prime editing. Nucleic Acids Res. 49, W499–W504 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Anderson, M. V., Haldrup, J., Thomsen, E. A., Wolff, J. H. & Mikkelsen, J. G. pegIT – a web-based design tool for prime editing. Nucleic Acids Res. 49, W505–W509 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Chow, R. D., Chen, J. S., Shen, J. & Chen, S. A web tool for the design of prime-editing guide RNAs. Nat. Biomed. Eng. 5, 190–194 (2021).

    Article  CAS  PubMed  Google Scholar 

  72. Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184–191 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Chen, P.-F. et al. Generation and characterization of human induced pluripotent stem cells (iPSCs) from three male and three female patients with CDKL5 deficiency disorder (CDD). Stem Cell Res. 53, 102276 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank D. Gao and T. Huang for helpful discussions and A. Vieira for feedback on this manuscript. We thank A. Anzalone and other Liu Laboratory members who advanced PE technology. Figures were created with BioRender.com. This work was supported by US NIH U01AI142756, RM1HG009490, R01EB031172 and R35GM118062, the Howard Hughes Medical Institute and the Bill & Melinda Gates Foundation. J.L.D., A.A.S., P.B.R. and P.J.C. are supported by the NSF Graduate Research Fellowship program. J.L.D. is supported by a Fannie and John Hertz Foundation Fellowship.

Author information

Author notes

  1. These authors contributed equally: Jordan L. Doman, Alexander A. Sousa.

Authors and Affiliations

  1. Merkin Institute of Transformative Technologies in Healthcare, The Broad Institute of MIT and Harvard, Cambridge, MA, USA

    Jordan L. Doman, Alexander A. Sousa, Peyton B. Randolph, Peter J. Chen & David R. Liu

  2. Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA

    Jordan L. Doman, Alexander A. Sousa, Peyton B. Randolph, Peter J. Chen & David R. Liu

  3. Howard Hughes Medical Institute, Harvard University, Cambridge, MA, USA

    Jordan L. Doman, Alexander A. Sousa, Peyton B. Randolph, Peter J. Chen & David R. Liu

Authors
  1. Jordan L. Doman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexander A. Sousa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peyton B. Randolph
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter J. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David R. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.L.D. and A.A.S. contributed equally and wrote elements of the introduction, protocol and figures. P.B.R. assisted with figure creation and provided advice on pegRNA optimization and design. P.J.C. performed optimization experiments and made figures. D.R.L. supervised the research and wrote parts of the manuscript. All authors edited the manuscript.

Corresponding author

Correspondence to David R. Liu.

Ethics declarations

Competing interests

J.L.D., A.A.S., P.B.R., P.J.C. and D.R.L. have filed patent applications on PE technologies and applications. P.J.C. is currently an employee of Prime Medicine. D.R.L. is a consultant and equity holder of Prime Medicine, Beam Therapeutics, Pairwise Plants and Chroma Medicine, companies that use genome editing or genome engineering.

Peer review

Peer review information

Nature Protocols thanks Sangsu Bae, Hyongbum H. Kim, Myungjae Song, Goosang Yu and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Related links

Key references using this protocol:

Anzalone, A. V. et al. Nature 576, 149–157 (2019): https://doi.org/10.1038/s41586-019-1711-4

Nelson, J. W. et al. Nat. Biotechnol. 40, 402–410 (2022): https://doi.org/10.1038/s41587-021-01039-7

Chen, P. J. et al. Cell 184, 5635–5652 (2021): https://doi.org/10.1016/j.cell.2021.09.018

Anzalone, A. V. et al. Nat. Biotechnol. 40, 731–740 (2022): https://doi.org/10.1038/s41587-021-01133-w

Supplementary information

Reporting Summary

Supplementary Table 1

pegRNA and nicking sgRNA sequences used in Fig. 7.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doman, J.L., Sousa, A.A., Randolph, P.B. et al. Designing and executing prime editing experiments in mammalian cells. Nat Protoc 17, 2431–2468 (2022). https://doi.org/10.1038/s41596-022-00724-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41596-022-00724-4

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing